PerkinElmer is releasing a new advanced automated, high-throughput quantitative pathology system that is able to image seven different colors per slide. This capability allows the Vectra 3 system to be used for monitoring up to seven biomarkers simultaneously, providing a more in-depth analysis of cancer activity and the effects of immunotherapy. It’s available in a 6-slide or 200-slide configuration.
Some details from the announcement:
The Vectra 3 system visualizes, analyses, quantifies and phenotypes immune cells in situ in formalin-fixed paraffin-embedded (FFPE) tissue sections, a process that can help provide researchers critical insight into the role of immune cells within solid tumors and the tumor microenvironment. It incorporates 10x whole slide imaging and the Phenochart™ whole slide viewer, allowing researchers to annotate and navigate slides with interactive interfaces to better identify regions of interest for detailed multispectral acquisition.